Establishment Labs Corp (ESTA): Kapitalisasi marang pendapatan
Establishment Labs (ESTA) previously experienced stagnation but has now entered an expansion phase, particularly following its entry into the US market. The company's average P/S on GURU.Markets analytics reflects this trend, with the current metric standing at 7.80. Growth is driven by surgeons' confidence in implant safety, while the Motiva digital ecosystem, which connects clinics with the vendor, ensures business resilience.
Rincian analitis perusahaan Motiva (ESTA)
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- indikator nilai buku ekuitas:
- statistik kawajiban utang lan likuiditas:
Koefisien Total Utang marang Modal Establishment Labs|ESTA - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Establishment Labs Inc|ESTA - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Motiva|ESTA - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Establishment Labs|Rasio jangkoan perantara establishmentlabs.com
- data bathi lan kelipatan valuasi:
ESTA - Bathi resik|Bathi resik sing dikarepake Establishment Labs|ESTA - Rasio rega marang bathi|Pangali forward rega marang bathi Establishment Labs Corp|ESTA - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Motiva|ESTA - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Establishment Labs|ESTA - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan establishmentlabs.com|ESTA - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Establishment Labs
- rincian pendapatan lan dodolan emiten:
Analisis umum perusahaan:ESTA establishmentlabs.com
The P/S multiple determines the market value of a business per unit of generated revenue, allowing for an assessment of the asset's overvaluation relative to its actual operating income. Analyzing the price-to-sales ratio serves as a portfolio stress-testing tool, revealing the vulnerability of Establishment Labs (ESTA) to geopolitical disruptions in raw material supplies and patent protection complexities, which directly impact sales stability.
Pesaing Establishment Labs
BSX (bostonscientific.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Edwards Lifesciences Corporation EW|RMD - Kapitalisasi marang pendapatan|OmniPod - Multiplikator P/S|Rega marang dodolan Zimmer Biomet Holdings|COO: Multiplikator P/S|Rasio kapitalisasi marang pendapatan ALGN|GMED (Globus Medical) - Multiplikator P/S|TransMedics Group Inc (TMDX) - Koefisien rega marang pendapatan|Multiplikator P/S ATEC|Kapitalisasi marang pendapatan Artivion Corp AORT|Multiplikator P/S ENOV (Enovis Corporation)|Multiplikator P/S integralife.com IART|BBNX - Rasio rega marang pendapatan|IRMD: Rasio rega marang pendapatan|EMBC (Embecta Inc.) - Kapitalisasi marang pendapatan|Tandem Corp - Rasio kapitalisasi pasar marang pendapatan|AXGN (AxoGen, Inc.) - Multiplikator P/S|Rega marang dodolan si-bone.com SIBN|Rasio rega marang pendapatan Orthofix (OFIX)|Bioventus Inc (BVS) - Multiplikator rega marang pendapatan|OrthoPediatrics - Kapitalisasi marang pendapatan|Multiplikator P/S Treace Corp TMCI|Strata Critical Medical Inc - Multiplikator P/S|Koefisien rega marang pendapatan carlsmed.com CARL|RxSight (RXST) - Rasio rega marang pendapatan|Rasio rega marang dodolan CLPT (ClearPoint Neuro)|Rasio rega marang pendapatan Stereotaxis Corp|Kapitalisasi marang pendapatan Neuronetics, Inc (STIM)|Multiplikator P/S SGHT|OBIO - Rega marang dodolan|Rasio rega marang pendapatan Anika Therapeutics, Inc. ANIK|NSPR: Rasio kapitalisasi marang pendapatan|ZJYL: Kapitalisasi marang pendapatan|Vivani Medical, Inc. - Kapitalisasi marang volume dodolan|XTNT: Multiplikator P/S|Rega marang dodolan n1mtc.com (NMTC)|Rasio rega marang pendapatan Modular Medical Inc|Myomo Inc. (MYO) - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan COCH (Envoy Medical, Inc)|Kapitalisasi marang volume dodolan VVOS|Multiplikator P/S NVNO (enVVeno Medical)|Multiplikator P/S Sintx Technologies Inc SINT|Tenon Medical - Multiplikator P/S|LFWD: Rasio rega marang pendapatan|autonomix.com (AMIX) - Rasio rega marang pendapatan|IVF (INVO Fertility Corp) - Rasio rega marang pendapatan|BBLG (Bone Biologics) - Multiplikator P/S|axonics.com (AXNX) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan BIOLASE (BIOL)|Koefisien rega marang pendapatan dynatronics.com|Multiplikator P/S FNA (Paragon 28)|Rasio kapitalisasi pasar marang pendapatan INVO
